Bagheri Amin, Sheikhi Nooshabadi Morteza, Ebrahimi Pouya, Nazari Roozbeh, Ramezani Pedram, Alirezaei Toktam
Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Int J Emerg Med. 2025 Jan 3;18(1):4. doi: 10.1186/s12245-024-00794-z.
Anticoagulants increase the risk of cardiac tamponade in patients with pericardial effusion (PE). Therefore, inappropriate administration of them in the presence of PE can lead to a catastrophic outcome. This study presents a patient with a provisional misdiagnosis of venous thromboembolism (VTE).
An 83-year-old Iranian female was transferred to the emergency department of a tertiary cardiology hospital complaining of neck swelling concomitant with chest pain and dyspnea. The patient had been diagnosed with jugular vein thrombosis in another local center, and since the chief complaint was neck swelling, she underwent Doppler sonography, and the diagnosis was confirmed. Subsequently, the treatment with unfractionated heparin was started. After 5 h, considering the worsening of symptoms with the suspicious diagnosis of COVID-19 based on her symptoms and laboratory data, a chest computed tomography scan was requested, which showed a massive PE. Subsequently, transthoracic echocardiography confirmed the diagnosis. The patient was immediately transferred to the operating room and underwent pericardiotomy. The post-surgery period was uneventful, and she was discharged 5 days later.
Patients with viral infections, specifically COVID-19, are at risk of undiagnosed severe pericardial effusions. Venous stasis in the jugular veins due to PE can mimic jugular vein thromboembolism, causing a wrong diagnosis. Since treating thrombosis can exacerbate tamponade to hemodynamic instability and collapse, sufficient investigation before starting anticoagulants is necessary.
Distinguishing VTE from PE is not always straightforward. Therefore, it is important to ensure physicians have reached an appropriate level of certainty about their diagnosis by performing precise diagnostics before using anticoagulants. Mismanagement with anti-thrombotics can result in catastrophic consequences. Therefore, taking an accurate history, performing a precise physical examination, and using rapid and available diagnostic modalities can avoid delays in definitive management.
抗凝剂会增加心包积液(PE)患者发生心脏压塞的风险。因此,在存在PE的情况下不恰当地使用抗凝剂可能导致灾难性后果。本研究报告了一名初步误诊为静脉血栓栓塞(VTE)的患者。
一名83岁的伊朗女性因颈部肿胀伴胸痛和呼吸困难被转至一家三级心脏病专科医院的急诊科。该患者在当地另一家中心被诊断为颈静脉血栓形成,由于主要症状是颈部肿胀,她接受了多普勒超声检查,诊断得到证实。随后,开始使用普通肝素进行治疗。5小时后,鉴于根据其症状和实验室数据怀疑诊断为2019冠状病毒病(COVID-19)且症状恶化,要求进行胸部计算机断层扫描,结果显示大量PE。随后,经胸超声心动图证实了诊断。患者立即被转至手术室并接受了心包切开术。术后恢复顺利,5天后出院。
病毒感染患者,尤其是COVID-19患者,有未被诊断出严重心包积液的风险。PE导致的颈静脉淤血可模仿颈静脉血栓栓塞,从而导致错误诊断。由于治疗血栓形成可能会使心脏压塞加重至血流动力学不稳定和衰竭,因此在开始使用抗凝剂之前进行充分的检查是必要的。
区分VTE和PE并不总是那么简单。因此,重要的是要确保医生在使用抗凝剂之前通过精确诊断达到适当的确信度。抗血栓药物管理不当可能导致灾难性后果。因此,准确采集病史、进行精确的体格检查以及使用快速且可用的诊断方法可以避免确定性治疗的延迟。